Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s...
BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, announced a collaboration with NMDP...
Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive...
Faro Health Inc., the leading SaaS platform for data-driven clinical development, is pleased to announce the appointment of Vivian DeWoskin as Chief Strategy Officer.
Vivian...
Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, announced that the U.S. Food and Drug Administration...
